• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性进行性多发性硬化症的病程及预后。一项流行病学研究结果

Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study.

作者信息

Minderhoud J M, van der Hoeven J H, Prange A J

机构信息

Department of Neurology, University Hospital, Groningen, The Netherlands.

出版信息

Acta Neurol Scand. 1988 Jul;78(1):10-5. doi: 10.1111/j.1600-0404.1988.tb03611.x.

DOI:10.1111/j.1600-0404.1988.tb03611.x
PMID:3176876
Abstract

In studies on the natural course of multiple sclerosis (MS), several forms of the disease are distinguished. The most important are the relapsing remitting and the chronic progressive forms. The relationship between these remains unclear. In a prospective epidemiological survey we studied the course of MS using the year in which the chronic-progressive phase started as a landmark. The reliability of this "year of progression" was examined in an observer agreement study. Data were acquired from 342 patients. Progression of the handicap was most rapid in case of a secondary progressive course, female sex, high relapse rate in the preceding remitting phase and "year of progression" at a higher age. Survival after the "year of progression" was lowest in the secondary progressive group. Determining the "year of progression" seems to be significant for the prognosis.

摘要

在对多发性硬化症(MS)自然病程的研究中,区分出了该疾病的几种形式。其中最重要的是复发缓解型和慢性进展型。二者之间的关系仍不明确。在一项前瞻性流行病学调查中,我们以慢性进展期开始的年份为标志研究了MS的病程。在一项观察者一致性研究中检验了这个“进展年份”的可靠性。数据来自342例患者。在继发进展型病程、女性、既往缓解期高复发率以及较高年龄出现“进展年份”的情况下,残疾进展最为迅速。继发进展组在“进展年份”后的生存率最低。确定“进展年份”似乎对预后具有重要意义。

相似文献

1
Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study.慢性进行性多发性硬化症的病程及预后。一项流行病学研究结果
Acta Neurol Scand. 1988 Jul;78(1):10-5. doi: 10.1111/j.1600-0404.1988.tb03611.x.
2
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
3
Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis.临床孤立综合征、复发缓解型和继发进展型多发性硬化症患者的长期随访
Mult Scler. 2003 Jun;9(3):260-74. doi: 10.1191/1352458503ms914oa.
4
Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.早期复发恢复不佳会影响多发性硬化症进展性病程的发作。
Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24.
5
Relapses and progression of disability in multiple sclerosis.多发性硬化症的复发与残疾进展
N Engl J Med. 2000 Nov 16;343(20):1430-8. doi: 10.1056/NEJM200011163432001.
6
Ten-year prognosis in multiple sclerosis: a better outcome in relapsing-remitting patients but not in primary progressive patients.多发性硬化症的十年预后:复发缓解型患者预后较好,但原发进展型患者并非如此。
Eur J Neurol. 2015 Mar;22(3):507-e35. doi: 10.1111/ene.12600. Epub 2014 Dec 16.
7
The natural history of multiple sclerosis: a geographically based study. 7. Progressive-relapsing and relapsing-progressive multiple sclerosis: a re-evaluation.多发性硬化症的自然史:一项基于地理区域的研究。7. 进展复发型和复发进展型多发性硬化症:重新评估。
Brain. 1999 Oct;122 ( Pt 10):1941-50. doi: 10.1093/brain/122.10.1941.
8
Secondary progressive multiple sclerosis: current knowledge and future challenges.继发进展型多发性硬化症:当前认知与未来挑战
Lancet Neurol. 2006 Apr;5(4):343-54. doi: 10.1016/S1474-4422(06)70410-0.
9
Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.多发性硬化症认知能力下降的预测:一项 5 年随访研究。
Brain. 2018 Sep 1;141(9):2605-2618. doi: 10.1093/brain/awy202.
10
Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging.通过定量磁共振成像确定的复发缓解型与慢性进展型多发性硬化症之间的差异。
Radiology. 1999 Mar;210(3):769-74. doi: 10.1148/radiology.210.3.r99mr44769.

引用本文的文献

1
The Role of MRI Lesions in Identifying Secondary Progressive Multiple Sclerosis: A Comprehensive Review.MRI病变在识别继发进展型多发性硬化中的作用:一项综述
J Clin Med. 2025 Jun 10;14(12):4114. doi: 10.3390/jcm14124114.
2
Systematic literature review and meta-analysis of the prevalence of secondary progressive multiple sclerosis in the USA, Europe, Canada, Australia, and Brazil.系统文献回顾和荟萃分析美国、欧洲、加拿大、澳大利亚和巴西的继发进展性多发性硬化症的患病率。
BMC Neurol. 2022 Aug 17;22(1):301. doi: 10.1186/s12883-022-02820-0.
3
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
脑 TSPO-PET 预测多发性硬化症的疾病进展与复发无关。
Brain. 2020 Dec 5;143(11):3318-3330. doi: 10.1093/brain/awaa275.
4
Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.进展性多发性硬化症患者的细胞因子谱及其与疾病进展和残疾的关系。
Mol Neurobiol. 2017 May;54(4):2950-2960. doi: 10.1007/s12035-016-9846-x. Epub 2016 Mar 29.
5
Relapses and disability accumulation in progressive multiple sclerosis.进展性多发性硬化症的复发与残疾累积
Neurology. 2015 Jan 6;84(1):81-8. doi: 10.1212/WNL.0000000000001094. Epub 2014 Nov 14.
6
Clinical prognostic factors in multiple sclerosis: a natural history review.多发性硬化症的临床预后因素:自然病史回顾。
Nat Rev Neurol. 2009 Dec;5(12):672-82. doi: 10.1038/nrneurol.2009.178.
7
The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease.CTLA-4 基因多态性与多发性硬化症患者 CTLA-4 蛋白表达水平相关,并与疾病易感性相关。
Immunology. 2009 Sep;128(1 Suppl):e787-96. doi: 10.1111/j.1365-2567.2009.03083.x. Epub 2009 Feb 17.
8
Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities.原发进展型和继发进展型多发性硬化症的自然史比较揭示了差异与相似之处。
J Neurol. 2009 Mar;256(3):374-81. doi: 10.1007/s00415-009-0039-7. Epub 2009 Mar 18.
9
Multiple sclerosis with a progressive course from onset in Lorraine-Eastern France.法国东部洛林地区起病即呈进展型的多发性硬化症。
J Neurol. 2007 Oct;254(10):1370-5. doi: 10.1007/s00415-007-0554-3. Epub 2007 Jun 25.
10
Primary progressive multiple sclerosis : current and future treatment options.原发性进行性多发性硬化症:当前及未来的治疗选择
CNS Drugs. 2005;19(5):369-76. doi: 10.2165/00023210-200519050-00001.